A new study from the Consortium of Eosinophilic Gastrointestinal Disease Researchers shows that dupilumab improves outcomes in eosinophilic gastritis.
Each month, we share summaries of recent Rare Diseases Clinical Research Network (RDCRN) grant-funded publications. Catch up on the latest RDCRN…